Top Gainers: Neurocrine Biosciences (NBIX), Axalta Coating (AXTA), ACCO Brands (ACCO), Criteo SA (CRTO)

Neurocrine Biosciences Inc. (NBIX) is up 7% in late trading following this morning’s announcement of AbbVie Inc. (ABBV) announcing positive top-line results from trial evaluating Elagolix in premenopausal women who suffer pain from endometriosis, a condition affecting an estimated 176 million women worldwide. AbbVie, working with Neurocrine Biosciences in developing Elagolix, anticipates bringing a proposal […] View the full post at: Top Gainers: Neurocrine Biosciences (NBIX), Axalta Coating (AXTA), ACCO Brands (ACCO), Criteo SA (CRTO) Related posts: Chiquita Brands: Don’t Go Bananas Over 1Q Warning Morgan Stanley Posts its First Quarterly Profit in a Year Zoom Technologies Beats Guidance